Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
Hiroki Ishiguro, Berhanu Geresu Kibret, Yasue Horiuchi, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 20

Showing 20 citing articles:

Beta-Caryophyllene, a Cannabinoid Receptor Type 2 Selective Agonist, in Emotional and Cognitive Disorders
Caterina Ricardi, Serena Barachini, G. Consoli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3203-3203
Open Access | Times Cited: 10
Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders
Maria de Fátima dos Santos Sampaio, Yara Bezerra de Paiva, Tuane Bazanella Sampaio, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 5, pp. 574-601
Open Access | Times Cited: 8
Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery
Siyuan Shen, Chao Wu, Zhiqian Yang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
How depression and antidepressant drugs affect endocannabinoid system?—review of clinical and preclinical studies
Jonasz Dragon, Ewa Obuchowicz
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 4511-4536
Closed Access | Times Cited: 3
Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation
Hong Zhu, Feng Xiao, Yao Xiao, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 9
Molecular Insights into Epigenetics and Cannabinoid Receptors
Balapal S. Basavarajappa, Shivakumar Subbanna
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1560-1560
Open Access | Times Cited: 15
Cannabis, Endocannabinoids and Brain Development: From Embryogenesis to Adolescence
Ricardo J. Rodrigues, Joana M. Marques, Attila Köfalvi
Cells (2024) Vol. 13, Iss. 22, pp. 1875-1875
Open Access | Times Cited: 2
The Antimicrobial Properties of Cannabis and Cannabis-Derived Compounds and Relevance to CB2-Targeted Neurodegenerative Therapeutics
HeeJue Hong, Lucy Sloan, Deepak Saxena, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1959-1959
Open Access | Times Cited: 12
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
Barbara Vuić, Tina Milos, Lucija Tudor, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3000-3000
Open Access | Times Cited: 11
The cannabinoid CB 2 receptor positive allosteric modulator EC21a exhibits complicated pharmacology in vitro
Aidong Qi, Xueqing Han, Marc Quitalig, et al.
Journal of Receptors and Signal Transduction (2024), pp. 1-9
Closed Access | Times Cited: 1
The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease
Maria Sofia Basile, Emanuela Mazzon
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2986-2986
Open Access | Times Cited: 7
Exploring the therapeutic potential of natural compounds modulating the endocannabinoid system in various diseases and disorders: review
Gidion Wilson, Lingling Yang, Xiaojuan Su, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1410-1444
Closed Access | Times Cited: 2
Toll-like receptor 4 in the interface between neuroimmune response and behavioral alterations caused by stress
Fábio José Coelho de Souza-Junior, Laura Colete Cunha, Sabrina F. Lisboa
Exploration of Neuroprotective Therapy (2022), pp. 182-209
Open Access | Times Cited: 4
A Translational Approach to Using Endocannabinoid Modulators for Targeting Opioid-Associated Memory
Saeideh Karimi‐Haghighi, Roghayeh Mozafari, Sara Chavoshinezhad, et al.
Current Addiction Reports (2024) Vol. 11, Iss. 5, pp. 894-915
Closed Access
G protein-coupled receptors in cochlea: Potential therapeutic targets for hearing loss
Xiangyu Ma, Jiamin Guo, Yaoyang Fu, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 2
Associations of cognitive decline, peripheral inflammatory factors and hippocampal subregions volume in knee osteoarthritis - a longitudinal MRI study
Yajun Wang, Guiyan Cai, Ming Li, et al.
Research Square (Research Square) (2023)
Open Access
WITHDRAWN: Associations of cognitive decline, peripheral inflammatory factors and hippocampal subregions volume in knee osteoarthritis - a longitudinal MRI study

Research Square (Research Square) (2023)
Open Access
A literature review on the therapeutic applicability of cannabidiol in epilepsy, multiple sclerosis and Parkinson's disease
Maria de Fátima dos Santos Sampaio, Yara Bezerra de Paiva, Tuane Bazanella Sampaio, et al.
Authorea (Authorea) (2023)
Open Access
Avaliação das consequências comportamentais da administração de um inibidor da via do TLR4 no córtex pré-frontal medial após exposição ao estresse e possível envolvimento do sistema endocanabinoide
Fábio José Coelho de Souza
(2023)
Open Access
Alcohol induced behavioral and immune perturbations are attenuated by activation of CB2 cannabinoid receptors
Aaliyah Roberts, Mahli Christian, Lizbeth Nivar Dilone, et al.
Advances in Drug and Alcohol Research (2023) Vol. 3
Open Access
Page 1

Scroll to top